What is a stock summary page? Click here for an overview.
Business Description
Daxor Corp
NAICS : 333314
SIC : 3841
ISIN : US2394671034
Description
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.98 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 7/9 | |||||
| Beneish M-Score | -2.25 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -32.7 | |||||
| 3-Year Book Growth Rate | 11.5 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.56 | |||||
| 9-Day RSI | 59.45 | |||||
| 14-Day RSI | 58.03 | |||||
| 3-1 Month Momentum % | -13.26 | |||||
| 6-1 Month Momentum % | -22.53 | |||||
| 12-1 Month Momentum % | -10.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.9 | |||||
| Shareholder Yield % | -1.05 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 25.15 | |||||
| FCF Margin % | 1.22 | |||||
| ROE % | 1.57 | |||||
| ROA % | 1.52 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 19.47 | |||||
| PB Ratio | 1.12 | |||||
| Price-to-Tangible-Book | 1.12 | |||||
| Price-to-Free-Cash-Flow | 8284.26 | |||||
| Price-to-Operating-Cash-Flow | 8284.26 | |||||
| EV-to-Revenue | 19.21 | |||||
| EV-to-FCF | 1620.31 | |||||
| Price-to-GF-Value | 2.35 | |||||
| Price-to-Projected-FCF | 2.35 | |||||
| FCF Yield % | 0.06 | |||||
| Forward Rate of Return (Yacktman) % | 15.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DXR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Daxor Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.131 | ||
| EPS (TTM) ($) | -0.09 | ||
| Beta | 0.09 | ||
| 3-Year Sharpe Ratio | -0.24 | ||
| 3-Year Sortino Ratio | -0.35 | ||
| Volatility % | 32.1 | ||
| 14-Day RSI | 58.03 | ||
| 14-Day ATR ($) | 0.431 | ||
| 20-Day SMA ($) | 7.84669 | ||
| 12-1 Month Momentum % | -10.58 | ||
| 52-Week Range ($) | 6.55 - 10 | ||
| Shares Outstanding (Mil) | 4.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Daxor Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Daxor Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Daxor Corp Frequently Asked Questions
What is Daxor Corp(DXR)'s stock price today?
The current price of DXR is $8.15. The 52 week high of DXR is $10.00 and 52 week low is $6.55.
When is next earnings date of Daxor Corp(DXR)?
The next earnings date of Daxor Corp(DXR) is 2025-08-29 Est..
Does Daxor Corp(DXR) pay dividends? If so, how much?
Daxor Corp(DXR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers